Blood Pressure Control and Compliance to Treatment in Hypertensive Patients With Metabolic Syndrome: a Study Based on Home Blood Pressure Telemonitoring and Assessment of Psychological Determinants (TELEBPMET)

Italian Institute of Telemedicine

Status: Completed

Conditions: Arterial Hypertension; Metabolic Syndrome

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01541566

TELEBPMET

Details and patient eligibility

About

The purpose of this study is to assess whether, in patients at high cardiovascular risk (hypertension with metabolic syndrome), long-term (1-year) blood pressure control is most effective when based on home blood pressure telemonitoring and on the feedback to the patient by the doctor between visits, or when based only on blood pressure determination during quarterly office visits.

Enrollment: 254 patients

Sex: All

Ages: 18 to 74 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Treated or untreated uncontrolled essential arterial hypertension (office systolic blood pressure >140 or diastolic >90 mmHg + day-time systolic blood pressure >135 or day-time diastolic blood pressure >85 mmHg)
• Metabolic syndrome (ATP III criteria)

Exclusion criteria

• Secondary arterial hypertension
• Severe liver or kidney disease
• Immunological disease
• Cardiac arrhythmias

Trial design

254 participants in 2 patient groups

Home blood pressure telemonitoring

Description:

Patients regularly monitoring their blood pressure at home with an electronic validated upper arm device, transmitting blood pressure values at monthly intervals to the doctors office through the Internet.

Conventional blood pressure measurement

Description:

Blood pressure measured only in the doctor's office during quarterly visits, without regular home blood pressure monitoring.